Glycogen Storage Disease Type II - 32 Studies Found
Withdrawn |
: High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease : Glycogen Storage Disease Type II : 2012-08-01 : Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding |
Completed |
: A Prospective, Observational Study in Patients With Late-Onset Pompe Disease : Glycogen Storage Disease Type II : 2004-02-10 |
Completed |
: A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease : Glycogen Storage Disease Type II : 2003-04-22 : Biological: Myozyme 20 mg/kg qow or 40mg/kg qow Othe |
Completed |
: Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 : Glycogen Storage Disease Type II : 2005-08-01 : Biological: Myozyme 20 mg/kg qow or 40 mg/kg qow Oth |
Recruiting |
: Respiratory Muscle Training in L-Onset Pompe Disease (LOPD) : Glycogen Storage Disease Type II : 2016-06-13 :
|
Recruiting |
: Pompe Disease Registry :
|
Completed |
: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease :
|
Approved for marketing |
: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease :
|
Completed |
: Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies :
|
Completed |
: Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies. :
|